Lawrence Otto Klein
Director; Director, Chief Executive Officer · 7 filings · Latest: Oct 1, 2026
Jade Biosciences, Inc.
Oruka Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ORKA | Lawrence Otto Klein | Director, Chief Executive Officer | Oct 1, 2026 | Sale | $83.62 | 25,000 | $2.1M | 923,128 | |
ORKA | Lawrence Otto Klein | Director, Chief Executive Officer | Oct 1, 2026 | Option Exercise | $7.80 | 25,000 | $195.0K | 948,128 | |
ORKA | LAWRENCE KLEIN | — | Oct 1, 2026 | Proposed Sale | $83.29 | 25,000 | $2.1M | — | |
ORKA | Lawrence Otto Klein | Director, Chief Executive Officer | Sep 15, 2026 | Sale | $95.71 | 2,452 | $234.7K | 923,128 | |
ORKA | Lawrence Otto Klein | Director, Chief Executive Officer | Sep 1, 2026 | Sale | $91.83 | 75,000 | $6.9M | 925,580 | |
ORKA | Lawrence Otto Klein | Director, Chief Executive Officer | Sep 1, 2026 | Option Exercise | $7.80 | 75,000 | $585.0K | 1,000,580 | |
ORKA | LAWRENCE KLEIN | — | Sep 1, 2026 | Proposed Sale | $92.62 | 75,000 | $6.9M | — | |
ORKA | Lawrence Otto Klein | Director, Chief Executive Officer | Jun 15, 2026 | Sale | $69.69 | 1,729 | $120.5K | 925,580 | |
ORKA | Lawrence Otto Klein | Director, Chief Executive Officer | Mar 16, 2026 | Sale | $41.30 | 1,729 | $71.4K | 927,309 |